Kong Lam - China Medical Chairman
| CHSYFDelisted Stock | USD 0.93 0.00 0.00% |
Chairman
Mr. Lam Kong serves as Executive Chairman of the Board, Chief Executive Officer, President of China Medical System Holdings Limited. He was appointed as an executive Director, on 18 December 2006. He acquired Shenzhen Kangzhe Pharmaceutical Co., Ltd. through his company over 20 years ago, building the business from a small company engaged in trading of pharmaceutical products to a leading pharmaceutical service company providing marketing, promotion and sale services. Mr. Lam is responsible for the creation, implementation and management of the Groups development and growth strategy and the management of the overall operation of the Group. Mr. Lam possesses clinical experience and has nearly 21 years of experience in marketing, promotion, sale and other valueadded services for pharmaceutical products in China. He received his bachelors degree in medicine from Zhanjiang Medical College in 1986, the name of which was changed to Guangdong Medical College in 1992. Mr. Lam is a member of the Nomination Committee of the Company and sole director of Treasure Sea Limited, one of the controlling shareholders of the Company.
| Age | 58 |
| Phone | 852 2369 7678 |
| Web | https://www.cms.net.cn |
China Medical Management Efficiency
The company has return on total asset (ROA) of 0.1324 % which means that it generated a profit of $0.1324 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.243 %, meaning that it generated $0.243 on every $100 dollars invested by stockholders. China Medical's management efficiency ratios could be used to measure how well China Medical manages its routine affairs as well as how well it operates its assets and liabilities.China Medical System has accumulated 573.81 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. China Medical System has a current ratio of 3.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist China Medical until it has trouble settling it off, either with new capital or with free cash flow. So, China Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Medical System sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 6 records | CHAIRMAN Age | ||
| Satish Reddy | Dr Reddys Laboratories | 52 | |
| Mazen Darwazah | Hikma Pharmaceuticals PLC | 65 | |
| G Prasad | Dr Reddys Laboratories | 59 | |
| Brian Markison | Lantheus Holdings | 65 | |
| Amir Elstein | Teva Pharma Industries | 64 | |
| Sol Barer | Teva Pharma Industries | 72 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 |
China Medical System Leadership Team
Elected by the shareholders, the China Medical's board of directors comprises two types of representatives: China Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Medical's management team and ensure that shareholders' interests are well served. China Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yanling Chen, CFO, Vice-Pres and Executive Director | ||
| Wai Wong, Chief Technical Officer | ||
| Kong Lam, Founder, Chairman of The Board, CEO and Member of Nomination Committee | ||
| Sanyan Wu, Company Secretary | ||
| Hongbing Chen, COO, Vice-President, Director of Sales and Marketing and Executive Director |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.36 % | |||
| Operating Margin | 0.37 % | |||
| Current Valuation | 3.84 B | |||
| Shares Outstanding | 2.45 B | |||
| Shares Owned By Insiders | 49.55 % | |||
| Shares Owned By Institutions | 19.25 % | |||
| Price To Earning | 8.10 X | |||
| Price To Book | 1.71 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |